The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Esomeprazole-Global Market Insights and Sales Trends 2025
Synopsis
Esomeprazole drug market in this report.
The global Esomeprazole market size is expected to reach US$ 212.2 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Esomeprazole in various end use industries. The expanding demands from the Gastroesophageal Reflux Disease, Duodenal Ulcers and Others,, are propelling Esomeprazole market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Esomeprazole market, driven by demand from China, the second largest economy with some signs of stabilising, the Esomeprazole market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Esomeprazole, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Esomeprazole market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Esomeprazole market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Esomeprazole sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Esomeprazole covered in this report include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc.
The global Esomeprazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Global Esomeprazole market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Esomeprazole market, Segment by Type:
Capsule
Tablet
Others
Global Esomeprazole market, by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Esomeprazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Esomeprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Esomeprazole drug market in this report.
The global Esomeprazole market size is expected to reach US$ 212.2 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Esomeprazole in various end use industries. The expanding demands from the Gastroesophageal Reflux Disease, Duodenal Ulcers and Others,, are propelling Esomeprazole market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Esomeprazole market, driven by demand from China, the second largest economy with some signs of stabilising, the Esomeprazole market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Esomeprazole, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Esomeprazole market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Esomeprazole market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Esomeprazole sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Esomeprazole covered in this report include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc.
The global Esomeprazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Global Esomeprazole market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Esomeprazole market, Segment by Type:
Capsule
Tablet
Others
Global Esomeprazole market, by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Esomeprazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Esomeprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Esomeprazole Market Overview
1.1 Esomeprazole Product Overview
1.2 Esomeprazole Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.2.3 Others
1.3 Global Esomeprazole Market Size by Type
1.3.1 Global Esomeprazole Market Size Overview by Type (2018-2029)
1.3.2 Global Esomeprazole Historic Market Size Review by Type (2018-2023)
1.3.3 Global Esomeprazole Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Esomeprazole Sales Breakdown by Type (2018-2023)
1.4.2 Europe Esomeprazole Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Esomeprazole Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Esomeprazole Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Esomeprazole Sales Breakdown by Type (2018-2023)
2 Global Esomeprazole Market Competition by Company
2.1 Global Top Players by Esomeprazole Sales (2018-2023)
2.2 Global Top Players by Esomeprazole Revenue (2018-2023)
2.3 Global Top Players by Esomeprazole Price (2018-2023)
2.4 Global Top Manufacturers Esomeprazole Manufacturing Base Distribution, Sales Area, Product Type
2.5 Esomeprazole Market Competitive Situation and Trends
2.5.1 Esomeprazole Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Esomeprazole Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Esomeprazole as of 2022)
2.7 Date of Key Manufacturers Enter into Esomeprazole Market
2.8 Key Manufacturers Esomeprazole Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Esomeprazole Status and Outlook by Region
3.1 Global Esomeprazole Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Esomeprazole Historic Market Size by Region
3.2.1 Global Esomeprazole Sales in Volume by Region (2018-2023)
3.2.2 Global Esomeprazole Sales in Value by Region (2018-2023)
3.2.3 Global Esomeprazole Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Esomeprazole Forecasted Market Size by Region
3.3.1 Global Esomeprazole Sales in Volume by Region (2024-2029)
3.3.2 Global Esomeprazole Sales in Value by Region (2024-2029)
3.3.3 Global Esomeprazole Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Esomeprazole by Application
4.1 Esomeprazole Market Segment by Application
4.1.1 Gastroesophageal Reflux Disease
4.1.2 Duodenal Ulcers
4.1.3 Others
4.2 Global Esomeprazole Market Size by Application
4.2.1 Global Esomeprazole Market Size Overview by Application (2018-2029)
4.2.2 Global Esomeprazole Historic Market Size Review by Application (2018-2023)
4.2.3 Global Esomeprazole Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Esomeprazole Sales Breakdown by Application (2018-2023)
4.3.2 Europe Esomeprazole Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Esomeprazole Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Esomeprazole Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Esomeprazole Sales Breakdown by Application (2018-2023)
5 North America Esomeprazole by Country
5.1 North America Esomeprazole Historic Market Size by Country
5.1.1 North America Esomeprazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Esomeprazole Sales in Volume by Country (2018-2023)
5.1.3 North America Esomeprazole Sales in Value by Country (2018-2023)
5.2 North America Esomeprazole Forecasted Market Size by Country
5.2.1 North America Esomeprazole Sales in Volume by Country (2024-2029)
5.2.2 North America Esomeprazole Sales in Value by Country (2024-2029)
6 Europe Esomeprazole by Country
6.1 Europe Esomeprazole Historic Market Size by Country
6.1.1 Europe Esomeprazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Esomeprazole Sales in Volume by Country (2018-2023)
6.1.3 Europe Esomeprazole Sales in Value by Country (2018-2023)
6.2 Europe Esomeprazole Forecasted Market Size by Country
6.2.1 Europe Esomeprazole Sales in Volume by Country (2024-2029)
6.2.2 Europe Esomeprazole Sales in Value by Country (2024-2029)
7 Asia-Pacific Esomeprazole by Region
7.1 Asia-Pacific Esomeprazole Historic Market Size by Region
7.1.1 Asia-Pacific Esomeprazole Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Esomeprazole Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Esomeprazole Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Esomeprazole Forecasted Market Size by Region
7.2.1 Asia-Pacific Esomeprazole Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Esomeprazole Sales in Value by Region (2024-2029)
8 Latin America Esomeprazole by Country
8.1 Latin America Esomeprazole Historic Market Size by Country
8.1.1 Latin America Esomeprazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Esomeprazole Sales in Volume by Country (2018-2023)
8.1.3 Latin America Esomeprazole Sales in Value by Country (2018-2023)
8.2 Latin America Esomeprazole Forecasted Market Size by Country
8.2.1 Latin America Esomeprazole Sales in Volume by Country (2024-2029)
8.2.2 Latin America Esomeprazole Sales in Value by Country (2024-2029)
9 Middle East and Africa Esomeprazole by Country
9.1 Middle East and Africa Esomeprazole Historic Market Size by Country
9.1.1 Middle East and Africa Esomeprazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Esomeprazole Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Esomeprazole Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Esomeprazole Forecasted Market Size by Country
9.2.1 Middle East and Africa Esomeprazole Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Esomeprazole Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca AB
10.1.1 AstraZeneca AB Company Information
10.1.2 AstraZeneca AB Introduction and Business Overview
10.1.3 AstraZeneca AB Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca AB Esomeprazole Products Offered
10.1.5 AstraZeneca AB Recent Development
10.2 Sandoz
10.2.1 Sandoz Company Information
10.2.2 Sandoz Introduction and Business Overview
10.2.3 Sandoz Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sandoz Esomeprazole Products Offered
10.2.5 Sandoz Recent Development
10.3 Actavis
10.3.1 Actavis Company Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actavis Esomeprazole Products Offered
10.3.5 Actavis Recent Development
10.4 Teva.
10.4.1 Teva. Company Information
10.4.2 Teva. Introduction and Business Overview
10.4.3 Teva. Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva. Esomeprazole Products Offered
10.4.5 Teva. Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Esomeprazole Products Offered
10.5.5 Mylan Recent Development
10.6 KernPharm
10.6.1 KernPharm Company Information
10.6.2 KernPharm Introduction and Business Overview
10.6.3 KernPharm Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.6.4 KernPharm Esomeprazole Products Offered
10.6.5 KernPharm Recent Development
10.7 Garmish Pharmaceuticals
10.7.1 Garmish Pharmaceuticals Company Information
10.7.2 Garmish Pharmaceuticals Introduction and Business Overview
10.7.3 Garmish Pharmaceuticals Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Garmish Pharmaceuticals Esomeprazole Products Offered
10.7.5 Garmish Pharmaceuticals Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Esomeprazole Products Offered
10.8.5 Sanofi Recent Development
10.9 Mepha
10.9.1 Mepha Company Information
10.9.2 Mepha Introduction and Business Overview
10.9.3 Mepha Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mepha Esomeprazole Products Offered
10.9.5 Mepha Recent Development
10.10 Saval Pharmaceutical
10.10.1 Saval Pharmaceutical Company Information
10.10.2 Saval Pharmaceutical Introduction and Business Overview
10.10.3 Saval Pharmaceutical Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Saval Pharmaceutical Esomeprazole Products Offered
10.10.5 Saval Pharmaceutical Recent Development
10.11 Stada
10.11.1 Stada Company Information
10.11.2 Stada Introduction and Business Overview
10.11.3 Stada Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Stada Esomeprazole Products Offered
10.11.5 Stada Recent Development
10.12 Blaskov
10.12.1 Blaskov Company Information
10.12.2 Blaskov Introduction and Business Overview
10.12.3 Blaskov Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Blaskov Esomeprazole Products Offered
10.12.5 Blaskov Recent Development
10.13 CQ Lummy
10.13.1 CQ Lummy Company Information
10.13.2 CQ Lummy Introduction and Business Overview
10.13.3 CQ Lummy Esomeprazole Sales, Revenue and Gross Margin (2018-2023)
10.13.4 CQ Lummy Esomeprazole Products Offered
10.13.5 CQ Lummy Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Esomeprazole Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Esomeprazole Industrial Chain Analysis
11.4 Esomeprazole Market Dynamics
11.4.1 Esomeprazole Industry Trends
11.4.2 Esomeprazole Market Drivers
11.4.3 Esomeprazole Market Challenges
11.4.4 Esomeprazole Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Esomeprazole Distributors
12.3 Esomeprazole Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
